Aspen Pharmacare | APN - Cash And Equivalent


Aspen Pharmacare reported ZAR16B in Cash and Equivalent for its fiscal semester ending in June of 2026.





Cash And Equivalent Change Date
Aspen Pharmacare ZAR 16B 10.38B Jun/2026
Cipla INR 10.18B 2.22B Mar/2026
Dr.Reddys Laboratories INR 11.2B 4.16B Jun/2026
Jiangsu Hengrui CNY 40.53B 428.6M Mar/2026
Kalbe Farma IDR 4.39T 344.8B Mar/2026
Life Healthcare ZAR 2.8B 1.65B Dec/2022
Netcare ZAR 1.5B 109M Dec/2022
Richter Gedeon HUF 135.63B 61.59B Dec/2024